{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:27:35Z","timestamp":1772130455848,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["pancreatology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.pan.2014.05.797","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T20:25:29Z","timestamp":1402518329000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival"],"prefix":"10.1016","volume":"14","author":[{"given":"Yong-Feng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2014.05.797_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics","volume":"60","author":"Jemal","year":"2010","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.pan.2014.05.797_bib2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2014.05.797_bib3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1572-0241.2007.01202.x","article-title":"The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. population-based study","volume":"102","author":"Shaib","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pan.2014.05.797_bib4","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1200\/JCO.2008.18.6288","article-title":"Postresection ca 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by rtog 9704","volume":"26","author":"Berger","year":"2008","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.pan.2014.05.797_bib5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.bjc.6605243","article-title":"Ca 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone","volume":"101","author":"Wasan","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pan.2014.05.797_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MPA.0b013e31823cd9df","article-title":"Frequencies and prognostic role of kras and braf mutations in patients with localized pancreatic and ampullary adenocarcinomas","volume":"41","author":"Schultz","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2014.05.797_bib7","first-page":"1346","article-title":"Kras mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas","volume":"26","author":"Krasinskas","year":"2013","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"key":"10.1016\/j.pan.2014.05.797_bib8","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1136\/gut.2005.083063","article-title":"Unfavourable prognosis associated with k-ras gene mutation in pancreatic cancer surgical margins","volume":"55","author":"Kim","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.pan.2014.05.797_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(03)00384-7","article-title":"Braf and k-ras gene mutations in human pancreatic cancers","volume":"199","author":"Ishimura","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pan.2014.05.797_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/JCO.2006.07.8824","article-title":"Peritumoral fibroblast sparc expression and patient outcome with resectable pancreatic adenocarcinoma","volume":"25","author":"Infante","year":"2007","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.pan.2014.05.797_bib11","first-page":"867","article-title":"Sparc mrna expression as a prognostic marker for pancreatic adenocarcinoma patients","volume":"30","author":"Miyoshi","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/bjc.2013.24","article-title":"Exploiting inflammation for therapeutic gain in pancreatic cancer","volume":"108","author":"Steele","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pan.2014.05.797_bib13","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/0008-5472.CAN-05-4128","article-title":"Tumor-driven evolution of immunosuppressive networks during malignant progression","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2011.12.004","article-title":"Inflammation and immune surveillance in cancer","volume":"22","author":"Chow","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.pan.2014.05.797_bib15","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/MPA.0b013e31822077b8","article-title":"Pancreatic cancer alters human cd4+ t lymphocyte function: a piece in the immune evasion puzzle","volume":"40","author":"Fogar","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2014.05.797_bib17","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.4049\/jimmunol.181.9.6595","article-title":"Carcinoembryonic antigen-specific but not antiviral cd4+ t cell immunity is impaired in pancreatic carcinoma patients","volume":"181","author":"Tassi","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pan.2014.05.797_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.gastro.2010.10.009","article-title":"Cxcl17 and icam2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis","volume":"140","author":"Hiraoka","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pan.2014.05.797_bib19","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","article-title":"Prevalence of foxp3+ regulatory t cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions","volume":"12","author":"Hiraoka","year":"2006","journal-title":"Clin Cancer Research Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/djm064","article-title":"Role of tumor endothelium in cd4+ cd25+ regulatory t cell infiltration of human pancreatic carcinoma","volume":"99","author":"Nummer","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pan.2014.05.797_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1477-2574.2011.00344.x","article-title":"Engineered t cells for pancreatic cancer treatment","volume":"13","author":"Katari","year":"2011","journal-title":"HPB Off J Int Hepato Pancreato Biliary Assoc"},{"key":"10.1016\/j.pan.2014.05.797_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ijc.24355","article-title":"An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen","volume":"125","author":"Cappello","year":"2009","journal-title":"Int J Cancer J Int Du Cancer"},{"key":"10.1016\/j.pan.2014.05.797_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1749-6632.2012.06777.x","article-title":"Tap expression level in tumor cells defines the nature and processing of mhc class i peptides for recognition by tumor-specific cytotoxic t lymphocytes","volume":"1283","author":"El Hage","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pan.2014.05.797_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1630","article-title":"Immunotherapy for pancreatic cancer - science driving clinical progress","volume":"5","author":"Laheru","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pan.2014.05.797_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pan.2014.05.797_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00423-006-0140-7","article-title":"Systemic immune dysfunction in pancreatic cancer patients","volume":"392","author":"Poch","year":"2007","journal-title":"Langenbeck's Arch Surg\/Dtsch Ges Chir"},{"key":"10.1016\/j.pan.2014.05.797_bib27","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/MPA.0b013e31824994ab","article-title":"Circulating lymphocyte subsets in pancreatic adenocarcinoma and their relationship to the stage of the disease","volume":"41","author":"Pezzilli","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2014.05.797_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MPA.0b013e3182373a66","article-title":"Circulating cd4+cd25+ regulatory t cells in patients with pancreatic cancer","volume":"41","author":"Yamamoto","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2014.05.797_bib29","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/onc.2013.223","article-title":"Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer","volume":"33","author":"Liu","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.pan.2014.05.797_bib30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2010.05.019","article-title":"Pebp1 downregulation is associated to poor prognosis in hcc related to hepatitis b infection","volume":"53","author":"Xu","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pan.2014.05.797_bib31","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1158\/1078-0432.CCR-09-0463","article-title":"Human leukocyte antigen-g protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection","volume":"15","author":"Cai","year":"2009","journal-title":"Clin Cancer Research Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib32","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jnci\/dji427","article-title":"Automated quantitative analysis (aqua) of in situ protein expression, antibody concentration, and prognosis","volume":"97","author":"McCabe","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pan.2014.05.797_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.09.037","article-title":"Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer","volume":"279","author":"Clark","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pan.2014.05.797_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2567.2009.03105.x","article-title":"Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma","volume":"128","author":"Zhao","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.pan.2014.05.797_bib35","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.4049\/jimmunol.179.10.6494","article-title":"Memory cd8+ t cells require cd28 costimulation","volume":"179","author":"Borowski","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pan.2014.05.797_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.immuni.2005.01.010","article-title":"Peripheral tolerance of cd8 t lymphocytes","volume":"22","author":"Redmond","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.pan.2014.05.797_bib37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory t cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.pan.2014.05.797_bib38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pan.2014.05.797_bib39","first-page":"606","article-title":"Increase of regulatory t cells in the peripheral blood of cancer patients","volume":"9","author":"Wolf","year":"2003","journal-title":"Clin Cancer Research Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib40","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-04-3232","article-title":"Increased populations of regulatory t cells in peripheral blood of patients with hepatocellular carcinoma","volume":"65","author":"Ormandy","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib41","first-page":"4404","article-title":"Increased populations of regulatory t cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers","volume":"9","author":"Ichihara","year":"2003","journal-title":"Clin Cancer Research Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib42","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/onc.2008.267","article-title":"Nk cells and cancer immunosurveillance","volume":"27","author":"Waldhauer","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.pan.2014.05.797_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bjc.6603840","article-title":"Nk-cell and t-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy","volume":"97","author":"Mozaffari","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pan.2014.05.797_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0003-4975(03)00165-6","article-title":"Suppression of the phytohemagglutinin response to lymphocytes is an independent prognosticator in patients with squamous cell carcinoma of the esophagus","volume":"76","author":"Nozoe","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pan.2014.05.797_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/immu.200390014","article-title":"Preferential apoptosis of cd56dim natural killer cell subset in patients with cancer","volume":"33","author":"Bauernhofer","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pan.2014.05.797_bib46","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/0008-5472.CAN-10-4179","article-title":"Profound coordinated alterations of intratumoral nk cell phenotype and function in lung carcinoma","volume":"71","author":"Platonova","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib47","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1158\/0008-5472.CAN-03-2646","article-title":"Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease","volume":"64","author":"Danna","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2014.05.797_bib48","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.4049\/jimmunol.164.4.2214","article-title":"Resection of solid tumors reverses t cell defects and restores protective immunity","volume":"164","author":"Salvadori","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pan.2014.05.797_bib49","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1510\/icvts.2011.270512","article-title":"Leukocyte subsets dynamics following open pulmonary lobectomy for lung cancer: a prospective, observational study","volume":"13","author":"Nosotti","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.pan.2014.05.797_bib50","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2217\/imt.11.10","article-title":"Potential targets for pancreatic cancer immunotherapeutics","volume":"3","author":"Dodson","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.pan.2014.05.797_bib51","doi-asserted-by":"crossref","first-page":"267539","DOI":"10.1155\/2011\/267539","article-title":"Current immunotherapeutic approaches in pancreatic cancer","volume":"2011","author":"Koido","year":"2011","journal-title":"Clin Dev Immunol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390314009168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390314009168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T20:31:48Z","timestamp":1649363508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390314009168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1424390314009168"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2014.05.797","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2014.05.797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 IAP and EPC. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}